<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Lymphocyte function-associated antigens 1 and 3 (LFA-1, LFA-3) and intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule 1 (ICAM-1) are cell surface <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules necessary for immune processes requiring intercellular contact </plain></SENT>
<SENT sid="1" pm="."><plain>It was recently proposed that malignant Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) may escape from immunosurveillance through the downregulation of LFA-1 (CD11a/CD18) or LFA-3 (CD58) and ICAM-1 (CD54) molecules </plain></SENT>
<SENT sid="2" pm="."><plain>Expression of these three <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> antigens was investigated in 19 BL lines </plain></SENT>
<SENT sid="3" pm="."><plain>LFA-1 or LFA-3 expression was found to be absent or low in 8 of 11 Epstein-Barr virus (EBV) genome positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>, but strongly expressed on <z:hpo ids='HP_0000001'>all</z:hpo> nonmalignant EBV genome positive lymphoblastoid cell lines (LCL) </plain></SENT>
<SENT sid="4" pm="."><plain>Negative or weak expression of LFA-1 and LFA-3 was also observed in 7 of 8 EBV genome negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>ICAM-1 was found to be expressed on the cell surface of the majority of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> lines </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> lines growing as individual cells did not express LFA-1, whereas clump-forming <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> lines expressed this marker involved in B-cell homotypic aggregation </plain></SENT>
<SENT sid="7" pm="."><plain>Expression of LFA-1 and LFA-3 was induced on in vitro <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> of EBV-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells with the immortalizing EBV strain B95-8, and weakly with the nonimmortalizing EBV strain P3HR1 </plain></SENT>
<SENT sid="8" pm="."><plain>EBNA2 and LMP, two EBV encoded proteins expressed in LCL and in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> infected with B95-8 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>/B95-8), are not expressed in P3HR1 infected <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>/P3HR1) </plain></SENT>
<SENT sid="9" pm="."><plain>Stable expression of EBNA2 after gene transfer in a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>/P3HR1 cell line did not restore the level of LFA-1 and LFA-3 found on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>/B95-8 cells </plain></SENT>
<SENT sid="10" pm="."><plain>In EBV-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells expressing LFA-1 and LFA-3, LMP was found coexpressed, supporting the recent finding of the role of LMP in B-cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> receptor activation </plain></SENT>
<SENT sid="11" pm="."><plain>Consequently, diminished LFA-1 and LFA-3 expression appears to be a common characteristic of numerous EBV-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> as well as EBV-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>These findings are discussed in the framework of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> pathogenesis </plain></SENT>
</text></document>